Delivery Order SPE2DB22D1106-SPE2DB24FFBE1
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$59K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $14,034.50, is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price type with a completion date of February 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,864.71, is for the delivery of 50 mg vials of the pharmaceutical product ACTIVASE. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This is a $13,305.93 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566872449 ACTIVASE 100 MG VIALS, with a period of performance through January 9, 2025. The contract is a firm-fixed-price type without any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTIVASE 100 MG VIALS. The $5,713.85 firm fixed price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical products and medical supplies to support military treatment...
This is a $14,164.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 100 mg vials of the pharmaceutical product ACTIVASE. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $11,458.84 order is for 50 mg ACTIVASE vials, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $2,864.71 contract is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, to support the DLA's Medical Supply Chain program. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2024. This appears to be a delivery order under...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $23,241.52 by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense, with a potential value...
The Defense Logistics Agency (DLA) awarded a $9,901.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 50 mg vials of the pharmaceutical product ACTIVASE. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen Drug Corp's primary contract vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,864.71 firm fixed-price contract is for the supply of the pharmaceutical product ACTIVASE 50 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with...